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abstract 
 
Introduction-Polycythemia is a laboratory finding in which there is an increased number of red 
blood cells, along with an accompanying increase in the concentration of hemoglobin in peripheral 
blood. . Considering the high frequency of jak2 mutation in patients with polycythemia vera, this 
study was conducted to distinguish primary polycythemia from secondary by jak2 mutation. 
Materials and Methods: This study was a descriptive epidemiologic. In this study, patients 
admitted to the hematology clinic with complaints of polycythemia, by definition, WHO, 
hemoglobin greater than g / dL 61 for ladies hemoglobin greater than g / dL5 / 61 for men, were 
enrolled. . Patients were given appropriate history and then patients were physically examined. For 
all patients, chest x-ray  and echocardiography and ultrasound was performed in terms of 
splenomegaly. . For patients, Jak2 Mutation RT-PCR Quntitative was performed. For mutated 
patients, BMA & B was performed. Finally, the data were analyzed using SPSS 6.71 software. 
Results: Of the 01 patients, (%2728) .7 were men and (6.7%8) were 61 women. Of these, 66 
patients (62728) had Jak2 mutation and .0 (%.7.8) patients lacked it. . Female sex with P.V = 
10111 and splenomegaly with P.V = 101/. and itching with P.V = 101/% had a significant 
relationship. There was a significant relationship between WBC and PLT with jak2 mutation. 
Mean hemoglobin was lower in patients with jak2 mutation. In fact, 6118 of patients with Jak2 
mutations had polycythemia vera. 
 Conclusion: The mutation level of Jak2 in patients with polycythemia vera in this study was 
comparable to previous studies. This test may result in early identification of myeloproliferative 
disorders (MPD) (one of which is a polycythemic manifestation). 
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